Endophthalmitis after cat bite has poor outcome particularly those associated with scleral injury. A 33-year-old Caucasian female was seen by her ophthalmologist 4 days after cat bite to her right eye with hand motion vision and obvious signs of acute endophthalmitis. She was treated with exploration and repair of scleral puncture wound, anterior chamber and vitreous cultures and intravitreal injections of vancomycin and ceftazidime. Cultures were positive for alpha hemolytic <i>Streptococcus</i>. She underwent a pars plana vitrectomy, cultures and repeat injection of the same antibiotics and intravitreal dexamethasone 2 days later. Cultures grew <i>Bacillus</i>. Endophthalmitis resolved and she regained 20/20 vision after cataract surgery 3 months later. Successful outcome of acute endophthalmitis following a cat bite to the sclera in this case was most likely due to prompt intravitreal antibiotics and early vitrectomy combined with supplemental intravitreal antibiotics and steroid therapy.
A full-term male infant with a history of in utero exposure to cocaine and alcohol was born with circumferential bilateral lower extremity ulcerations and skin hypoplasia over the same region (Figure). Upon light touch of these lesions, the infant became restless and fussy. A thorough dermatologic physical examination revealed dystrophy of several toenails involved with the ulcerations. Two punch biopsies from distinct areas of the margin of the ulceration revealed a central area of thin epidermis with underlying elastolysis, fibrosis, and an absence of adnexal structures that was consistent with aplasia cutis congenita. The rest of the biopsy showed adnexal structures and overlying subepidermal split with minimal inflammation suggestive of epidermolysis bullosa (EB). Aplasia cutis congenita with EB and nail dystrophy is highly suggestive of the clinical variant of EB, Bart syndrome. Genetic testing showed heterozygosity for p.Gly2043Arg (GGG>AGG): c.6127 G>A in exon 73 of COL7A1, the variant responsible for dominant dystrophic EB. The patient's parents were negative for the mutation. COL7A1 is expressed in basal keratinocytes of the epidermis and encodes for type VII collagen fibrils that stabilize the skin's structural integrity. 1 Pathogenic variants lead to the blistering of EB. 2 Genetic testing is currently the gold standard given the increasing prevalence of EB. 3 Aplasia cutis congenita, the congenital absence of dermis and epidermis, can be diffuse or localized, and is most commonly located on the scalp. Its etiology is unknown but may be multifactorial, involving genetics, teratogens, or vascular compromise. It may be solitary or present as a syndrome associated with skin and/or mucosal fragility. 4 Bart syndrome is the triad of congenital localized absence of the skin (aplasia cutis), mucocutaneous blisters, and nail deformities inherited in an autosomal dominant manner. Sporadic mutations involving COL7A1 may be seen, as with this patient. The aplasia cutis associated with Bart syndrome usually resolves with proper wound care over 6-8 weeks, granulating in with scarring. 5 Dominant dystrophic EB, however, remains a lifelong challenge. Those afflicted with the disease are often called "butterfly children" in popular media due to the delicate nature of their skin. Skin fragility and bullae are common on acral surfaces and the extremities, especially when children attain mobility. When blisters form, they should be punctured with a sterile needle and covered with petrolatum gauze. Open wounds can be managed with nonadherent dressings and topical or oral antibiotics as required, while modalities applying pressure, such as tape, can precipitate further blisters and should be avoided. Scarring over joints further restricts range of motion and necessitates appropriate physical therapy. 6 Caregiver education is the single most important intervention in minimizing bullae formation, life-threatening infection, and scarring. The patient's mother has since been able to intervene appropriately, and the disease has...
We present 2 cases of iatrogenic retinal penetration from intravitreal (IVT) injections in a retrospective noncomparative case series of 2 patients. The first patient, an 81-year-old Caucasian male, developed dense vitreous hemorrhage soon after receiving an IVT bevacizumab injection for macular edema from central retinal vein occlusion. A 25-g vitrectomy 1 week later showed a retinal hole surrounded by fresh hemorrhages in the same quadrant as the IVT injection. The second patient, an 87-years-old male, developed a retinal detachment after 28 injections of anti-VEGF medications for neovascular AMD. A peripheral round hole was observed during vitrectomy without any lattice degeneration in the same quadrant as prior IVT injections. Both eyes were pseudophakic, had normal axial lengths, and received injections without measuring the injection site. Retinal penetration from IVT injections can result in serious sight-threatening complications. Measuring the injection site from the limbus should be part of safe IVT injection technique.
<i>Candida dubliniensis</i> is an emerging pathogen implicated in a variety of infections in immunocompromised hosts. A 79-year-old male with autoimmune pancytopenia on chronic oral steroid therapy was admitted for suspected sepsis and started on empirical antibiotics and micafungin. He developed floaters and decreased vision while on this regimen and was diagnosed with bilateral candida endophthalmitis. Blood cultures grew <i>C.</i> <i>dubliniensis.</i>Intravenous therapy was switched to voriconazole and amphotericin B. He also received aggressive intravitreal antifungal therapy consisting of 100 μg/0.1 mL voriconazole (4 OD, 3 OS) and 5 μg/0.1 mL amphotericin B (3 OD, 1 OS) over 2 weeks that resulted in local control of infection. The right eye developed a retinal detachment 1 month after initial presentation that was repaired by 25-gauge pars plana vitrectomy, scleral buckle, laser and silicone oil. At the 15-month follow-up exam, subsequent to silicone oil removal, membrane peel and cataract surgery, OD visual acuity had improved to 20/80. OS was phakic and 20/25. Aggressive intravitreal antifungal therapy combined with intravenous therapy may control endophthalmitis and avoid the risks associated with pars plana vitrectomy during acute infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.